[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
October 12, 1994

Study Groups Make Vaccine Recommendations

JAMA. 1994;272(14):1088-1090. doi:10.1001/jama.1994.03520140018008

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


SOME ADVERSE reactions and other warnings about vaccines cited in three reports from the Institute of Medicine (IOM) should not be incorporated into public policies regarding immunization, says an ad hoc subcommittee of the National Vaccine Advisory Committee formed to help the Assistant Secretary for Health translate the findings of the IOM reports into national policy.

The reports are Adverse Effects of Pertussis and Rubella Vaccines, Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality, and DPT Vaccine and Chronic Nervous System Dysfunction.

The subcommittee's review of the IOM's report was summarized at a meeting of the Food and Drug Administration's (FDA) advisory committee on Vaccines and Related Products by Theodore C. Eickhoff, MD, of the Division of Infectious Diseases, University of Colorado Health Sciences Center, Denver. Eickhoff represented the FDA's committee during the discussions.

The National Vaccine Advisory Committee formed the subcommittee, which met this March, to review

First Page Preview View Large
First page PDF preview
First page PDF preview